Cargando…
Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine
Coxsackievirus B (CVB) enteroviruses are common pathogens that can cause acute and chronic myocarditis, dilated cardiomyopathy, aseptic meningitis, and they are hypothesized to be a causal factor in type 1 diabetes. The licensed enterovirus vaccines and those currently in clinical development are tr...
Autores principales: | Hankaniemi, Minna M., Baikoghli, Mo A., Stone, Virginia M., Xing, Li, Väätäinen, Outi, Soppela, Saana, Sioofy-Khojine, Amirbabak, Saarinen, Niila V. V., Ou, Tingwei, Anson, Brandon, Hyöty, Heikki, Marjomäki, Varpu, Flodström-Tullberg, Malin, Cheng, R. Holland, Hytönen, Vesa P., Laitinen, Olli H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565060/ https://www.ncbi.nlm.nih.gov/pubmed/32846899 http://dx.doi.org/10.3390/microorganisms8091287 |
Ejemplares similares
-
A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses
por: Saarinen, Niila V. V., et al.
Publicado: (2018) -
A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes
por: Stone, Virginia M., et al.
Publicado: (2017) -
Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect
por: Stone, Virginia M., et al.
Publicado: (2021) -
Antibody Responses against Enterovirus Proteases are Potential Markers for an Acute Infection
por: Saarinen, Niila V. V., et al.
Publicado: (2020) -
A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates
por: Stone, V. M., et al.
Publicado: (2020)